Streetbeat News

Equity Actions

ORMP

Oramed Pharmaceuticals has authorized a $20 million stock buyback program.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:09 pm

SGH

SMART Global Holdings has appointed Nate Olmstead as Senior Vice President and Chief Financial Officer. This leadership change is expected to bring new strategic direction to the company's financial operations.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:06 pm

NUWE

Nuwellis, Inc. (NUWE) has announced a 1-for-35 reverse stock split, which will consolidate every 35 shares of its common stock into one share. This move is aimed at regaining compliance with the Nasdaq's minimum bid price requirement.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:46 pm

ALUR

Allurion has announced an underwritten public offering of up to $20 million in common stocks and warrants.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:36 pm

DMAC

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) announced an $11.8 million private placement, issuing 4.72 million common shares at $2.50 per share. The transaction is expected to close around June 28, 2024, pending customary closing conditions.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:17 pm

SRE

Aramco and Sempra announced that their respective subsidiaries have executed a non-binding Heads of Agreement (HoA) for equity and offtake from the Port Arthur LNG Phase 2 project. Financial terms were not disclosed. The parties expect to finalize binding agreements with similar terms, subject to various conditions.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:13 pm

CNSP

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) announced a registered direct offering and concurrent private placement of 568,000 shares at $2.45 per share, expected to close on June 27, 2024. The gross proceeds are anticipated to be approximately $1.39 million.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:04 pm

TSHA

Taysha Gene Therapies shares are trading lower following the announcement of a $75 million underwritten public offering of common stock and pre-funded warrants.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:45 am

GLSI

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) will join the Russell 2000 and 3000 Indexes on July 1, 2024, following the annual reconstitution. This inclusion is expected to increase institutional ownership and reflects the company's progress in its Phase III clinical trial, FLAMINGO-01.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:37 am

APTV

DJT

GIS

LRMR

QD

TSHA

WOR

WVE

Worthington Enterprises, Taysha Gene Therapies, General Mills, and other major stocks are experiencing declines in Wednesday's pre-market session. Worthington Enterprises missed earnings and revenue estimates, leading to a 7.5% drop. Taysha Gene Therapies fell 14% due to a proposed public offering. General Mills slipped 4.5% following its fourth-quarter results.

Portfolio Pulse from Avi Kapoor

June 26, 2024 | 11:36 am